DNA Methylation and Ischemic Stroke Risk: An Epigenome-Wide Association Study.

BACKGROUND Ischemic stroke (IS) risk heritability is partly explained by genetics. Other heritable factors, such as epigenetics, could explain an unknown proportion of the IS risk. The objective of this study is to evaluate DNA methylation association with IS using epigenome-wide association studies (EWAS). METHODS  We performed a two-stage EWAS comprising 1,156 subjects. Differentially methylated positions (DMPs) and differentially methylated regions (DMRs) were assessed using the Infinium 450K and EPIC BeadChip in the discovery cohort (252 IS and 43 controls). Significant DMPs were replicated in an independent cohort (618 IS and 243 controls). Stroke subtype associations were also evaluated. Differentially methylated cell-type (DMCT) was analyzed in the replicated CpG sites using EpiDISH. We additionally performed pathway enrichment analysis and causality analysis with Mendelian randomization for the replicated CpG sites. RESULTS  A total of 957 CpG sites were epigenome-wide-significant (p ≤ 10-7) in the discovery cohort, being CpG sites in the top signals (logFC = 0.058, p = 2.35 × 10-22; logFC = 0.035, p = 3.22 × 10-22, respectively). ZFHX3 and MAP3K1 were among the most significant DMRs. In addition, 697 CpG sites were replicated considering Bonferroni-corrected p-values (p < 5.22 × 10-5). All the replicated DMPs were associated with risk of cardioembolic, atherothrombotic, and undetermined stroke. The DMCT analysis demonstrated that the significant associations were driven by natural killer cells. The pathway enrichment analysis showed overrepresentation of genes belonging to certain pathways including oxidative stress. ZFHX3 and MAP3K1 methylation was causally associated with specific stroke-subtype risk. CONCLUSION  Specific DNA methylation pattern is causally associated with IS risk. These results could be useful for specifically predicting stroke occurrence and could potentially be evaluated as therapeutic targets.

[1]  M. Esteller,et al.  Identification of 20 novel loci associated to ischemic stroke. Epigenome-Wide Association Study , 2019, bioRxiv.

[2]  L. Elnitski,et al.  MethylToSNP: identifying SNPs in Illumina DNA methylation array data , 2019, Epigenetics & Chromatin.

[3]  Carlos Cruchaga,et al.  Validation of a clinical-genetics score to predict hemorrhagic transformations after rtPA. , 2019, Neurology.

[4]  Chen Peng,et al.  Epigenome-Wide Association Study Indicates Hypomethylation of MTRNR2L8 in Large-Artery Atherosclerosis Stroke. , 2019, Stroke.

[5]  F. Sohrabji,et al.  Sex hormones and stroke: Beyond estrogens , 2019, Hormones and Behavior.

[6]  Devin C. Koestler,et al.  pwrEWAS: a user-friendly tool for comprehensive power estimation for epigenome wide association studies (EWAS) , 2019, BMC Bioinformatics.

[7]  M. Moskowitz,et al.  Glucocorticoids Regulate Bone Marrow B Lymphopoiesis After Stroke , 2019, Circulation research.

[8]  Ciro Indolfi,et al.  MicroRNAs as Diagnostic and Prognostic Biomarkers in Ischemic Stroke—A Comprehensive Review and Bioinformatic Analysis , 2018, Cells.

[9]  C. Sudlow,et al.  Genome‐wide meta‐analysis identifies 3 novel loci associated with stroke , 2018, Annals of neurology.

[10]  Shijie C. Zheng,et al.  Identification of differentially methylated cell-types in Epigenome-Wide Association Studies , 2018, Nature Methods.

[11]  Stephen R. Williams,et al.  Epigenome-Wide Analyses Identify Two Novel Associations With Recurrent Stroke in the Vitamin Intervention for Stroke Prevention Clinical Trial , 2018, Front. Genet..

[12]  George Davey Smith,et al.  Meffil: efficient normalization and analysis of very large DNA methylation datasets , 2018, Bioinform..

[13]  Valeriia Haberland,et al.  The MR-Base platform supports systematic causal inference across the human phenome , 2018, eLife.

[14]  Andrew D. Johnson,et al.  Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes , 2018, Nature Genetics.

[15]  Fenghua Chen,et al.  Frequencies of circulating B- and T-lymphocytes as indicators for stroke outcomes , 2017, Neuropsychiatric disease and treatment.

[16]  M. Nakatochi,et al.  Epigenome-wide association of myocardial infarction with DNA methylation sites at loci related to cardiovascular disease , 2017, Clinical Epigenetics.

[17]  Wei-Min Chen,et al.  GRECOS Project (Genotyping Recurrence Risk of Stroke): The Use of Genetics to Predict the Vascular Recurrence After Stroke , 2017, Stroke.

[18]  Peter W. Laird,et al.  Comprehensive characterization, annotation and innovative use of Infinium DNA methylation BeadChip probes , 2016, Nucleic acids research.

[19]  Ulf Gyllensten,et al.  Epigenome-wide association study reveals differential DNA methylation in individuals with a history of myocardial infarction. , 2016, Human molecular genetics.

[20]  J. Montaner,et al.  PPM1A Methylation Is Associated With Vascular Recurrence in Aspirin-Treated Patients , 2016, Stroke.

[21]  Jens-Peter Volkmer,et al.  CD47 blocking antibodies restore phagocytosis and prevent atherosclerosis , 2016, Nature.

[22]  P. Eline Slagboom,et al.  Controlling bias and inflation in epigenome- and transcriptome-wide association studies using the empirical null distribution , 2016, bioRxiv.

[23]  J. Montaner,et al.  TRAF3 Epigenetic Regulation Is Associated With Vascular Recurrence in Patients With Ischemic Stroke , 2016, Stroke.

[24]  G. Nan,et al.  The Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway as a Discovery Target in Stroke , 2016, Journal of Molecular Neuroscience.

[25]  J. Lee,et al.  Loci associated with ischaemic stroke and its subtypes (SiGN): a genome-wide association study , 2016, The Lancet Neurology.

[26]  D. Corella,et al.  Identification of a new locus and validation of previously reported loci showing differential methylation associated with smoking. The REGICOR study , 2015, Epigenetics.

[27]  R. Slieker,et al.  Design, measurement and processing of region-specific DNA methylation assays: the mass spectrometry-based method EpiTYPER , 2015, Front. Genet..

[28]  Tom R. Gaunt,et al.  Epigenome-wide association of DNA methylation markers in peripheral blood from Indian Asians and Europeans with incident type 2 diabetes: a nested case-control study. , 2015, The lancet. Diabetes & endocrinology.

[29]  Peter L Molloy,et al.  De novo identification of differentially methylated regions in the human genome , 2015, Epigenetics & Chromatin.

[30]  L. Caplan,et al.  Lacunar Infarction and Small Vessel Disease: Pathology and Pathophysiology , 2015, Journal of stroke.

[31]  J. Montaner,et al.  Global DNA Methylation of Ischemic Stroke Subtypes , 2014, PloS one.

[32]  F. Shi,et al.  Ischemic neurons recruit natural killer cells that accelerate brain infarction , 2014, Proceedings of the National Academy of Sciences.

[33]  Andrew E. Teschendorff,et al.  ChAMP: 450k Chip Analysis Methylation Pipeline , 2014, Bioinform..

[34]  C. Sudlow,et al.  Genetic Heritability of Ischemic Stroke and the Contribution of Previously Reported Candidate Gene and Genomewide Associations , 2012, Stroke.

[35]  Guangchuang Yu,et al.  clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.

[36]  D. Corbett,et al.  Transport of epidermal growth factor in the stroke-injured brain. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[37]  Elisa Cuadrado-Godia,et al.  Acute stroke unit care and early neurological deterioration in ischemic stroke , 2008, Journal of Neurology.

[38]  E. Lo,et al.  Interactions Between p38 Mitogen-Activated Protein Kinase and Caspase-3 in Cerebral Endothelial Cell Death After Hypoxia-Reoxygenation , 2003, Stroke.

[39]  G. Schlaug,et al.  Is the Association of National Institutes of Health Stroke Scale Scores and Acute Magnetic Resonance Imaging Stroke Volume Equal for Patients With Right- and Left-Hemisphere Ischemic Stroke? , 2002, Stroke.

[40]  M. E. Moseley,et al.  Correlation of perfusion- and diffusion-weighted MRI with NIHSS score in acute (<6.5 hour) ischemic stroke , 1998, Neurology.

[41]  David Lee Gordon,et al.  Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial , 1993, Stroke.

[42]  Zhao Zhang,et al.  NK cells in cerebral ischemia. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[43]  G. Fan,et al.  DNA Methylation and Its Basic Function , 2013, Neuropsychopharmacology.

[44]  C. Sudlow,et al.  Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE Collaboration): a meta-analysis of genome-wide association studies , 2012, The Lancet Neurology.

[45]  E. Feierstein,et al.  DNA Methylation of the First Exon Is Tightly Linked to Transcriptional Silencing , 2011, PloS one.